Author/Authors :
de Jong، نويسنده , , Mirjam M and Hofstra، نويسنده , , Robert M.W and Kooi، نويسنده , , Krista A and Westra، نويسنده , , Jantine L and Berends، نويسنده , , Maran J.W and Wu، نويسنده , , Ying and Hollema، نويسنده , , Harry and van der Sluis، نويسنده , , Tineke and van der Graaf، نويسنده , , Winette T.A and de Vries، نويسنده , , Elisabeth G.E and Schaapveld، نويسنده , , Michael and Sijm، نويسنده ,
Abstract :
Recently we identified a new variant, S845G, in the MLH3 gene in 7 out of 327 patients suspected of hereditary nonpolyposis colorectal cancer but not fulfilling the Amsterdam criteria and in 1 out of 188 control subjects. As this variant might play a role in causing sporadic colorectal cancer, we analyzed its prevalence in sporadic colorectal cancer patients. We analyzed a small part of exon 1 of the MLH3 gene, including the S845G variant, in germline DNA of 467 white sporadic colorectal cancer patients and 497 white controls. The S845G variant was detected in five patients and eight controls; the results thus indicate that this variant does not confer an increased colorectal cancer risk. Another variant (P844L) was clearly a polymorphism. Three other missense variants were rare and the sample size of the study was too small to conclude whether they are pathogenic. In conclusion, no association was observed between two MLH3 variants (P844L and S845G) and colorectal cancer risk.
